Yomesan 500 mg Kautabletten জার্মানি - জার্মান - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

yomesan 500 mg kautabletten

emra-med arzneimittel gmbh (3263935) - niclosamid - kautablette - niclosamid (6917) 500 milligramm

Lacosamide Adroiq ইউরোপীয় ইউনিয়ন - জার্মান - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lacosamid - epilepsie - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.